HealthQuill GLP-1 agonists
https://oag.ca.gov/news/press-releases/attorney-general-bonta-sues-nations-largest-insulin-makers-pharmacy-benefit
Drugs Health Medical

New drug therapy boosts insulin production by 700% in diabetic mice

HQ  Team July 16, 2024: A new animal study has found a new therapy that is able to boost inuslin-producing cells by 700%.

Read More
Cancer patients and survivors who drink alcohol make their treatment less effective and raise their chances of the disease returning — an exigency often ignored by caretakers.
Drugs Health Medical Pharma

Medications for obesity show promise in curbing alcohol cravings

Bharti Jayshankar January 26, 2024: A recent study has uncovered an unexpected benefit of medications commonly prescribed for obesity and type 2 diabetes:.

Read More
US-based Pacific Northwest National Laboratory, Microsoft Corp., and Micron Technology have joined hands to make computational chemistry available to researchers and industrial users.
Drugs Health Pharma

Roche forays into weight-loss therapy, buys Carmot for $2.7 billion

HQ Team December 4, 2023: In a strategic push into the obesity and diabetes treatment market, Roche, a leading pharmaceutical company, has finalized.

Read More
Semaglutide based weightloss drugs tied to increased suicide risk in a new study
Drugs Health Pharma

EMA expands probe into suicidal thoughts linked to weight loss drugs

HQ Team December 2, 2023: The European Medicines Agency (EMA) is intensifying its investigation into the potential link between certain GLP-1 receptor agonist.

Read More
Drugs Health Medical

Novel long-acting GLP-1 agonist offers hope for type 2 diabetics

HQ Team November 4, 2023: Scientists at the University of Tabriz, Iran, have done pioneering work on a long-acting GLP-1 agonist that holds.

Read More
X